ArticleBMJ (Clinical research ed.)2026

Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study.

Miao Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.